June 21, 2023

69 Years of Phapros' Contribution to the Development of Indonesia's Pharmaceutical Sector

Phapros has achieved in terms of financial performance, contributions to society through the TJSL program, and the production of 500 million units of Blood Enhancing Tablets (TTD)....

See More
June 08, 2023

Public Expose: Phapros' (PEHA) 2023 Strategy Focuses on Innovative Business Development, Digitalization, and Human Resources Development

Phapros held its Annual General Meeting of Shareholders for the 2022 fiscal year, followed by a public expose by the company...

See More
May 31, 2023

Phapros Expands Product Development Through Collaboration and Innovation

Phapros is currently undertaking product development initiatives through strategic collaborations with various parties, including its subsidiary PT Lucas Djaja, as well as domestic n global....

See More
May 23, 2023

Digitalization of Technology Becomes the Solution for the Pharmaceutical Industry

Digital transformation has become a necessity in today's industrial world, especially in the pharmaceutical sector....

See More
April 28, 2023

Phapros recorded 8.9% growth for its ethical products in the first quarter of 2023.

Phapros CEO, Hadi Kardoko, stated that the growth of Phapros' branded prescription drugs (ethical products) in the first quarter of 2023 increased by 8.9% compared to the previous year....

See More
April 11, 2023

Welcoming the 2023 Eid al-Fitr Homecoming, Phapros Prepares Tens of Thousands of Product Packages and Antimo Posts

PT Phapros Tbk is preparing various programs to enliven the 2023 Eid al-Fitr homecoming moment with its legendary product, Antimo....

See More